(2S,4S,5R)-2-[(1'R)-1',2'-DIHYDROXYETHYL]-4-METHYL-5-PHENYL-3-PARA-TOLYLSULFONYLOXAZOLIDINE;ANTI-ISOMER
Compound with spectra: 1 NMR
![(2S,4S,5R)-2-[(1'R)-1',2'-DIHYDROXYETHYL]-4-METHYL-5-PHENYL-3-PARA-TOLYLSULFONYLOXAZOLIDINE;ANTI-ISOMER](/api/compound/HU7mYpMxmr0.png?ph=true&h=300&w=458 "(2S,4S,5R)-2-[(1'R)-1',2'-DIHYDROXYETHYL]-4-METHYL-5-PHENYL-3-PARA-TOLYLSULFONYLOXAZOLIDINE;ANTI-ISOMER")
| SpectraBase Compound ID | HU7mYpMxmr0 |
|---|---|
| InChI | InChI=1S/C19H23NO5S/c1-13-8-10-16(11-9-13)26(23,24)20-14(2)18(15-6-4-3-5-7-15)25-19(20)17(22)12-21/h3-11,14,17-19,21-22H,12H2,1-2H3 |
| InChIKey | HRZGEHPDKKEVNQ-UHFFFAOYSA-N |
| Mol Weight | 377.46 g/mol |
| Molecular Formula | C19H23NO5S |
| Exact Mass | 377.129694 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
8-[(p-Methylphenyl)sulfonyl]-6-oxa-8-azabicyclo[3.2.1]oct-3-en-2-yl acetate
2H-1,2-benzothiazin-4-ol, 3-[[4-(dimethylamino)phenyl]methyl]-3,4-dihydro-2-(1-methylethyl)-, 1,1-dioxide
trans-N-p-Toluenesulfonyl-5-ethyl-4-(1-allyl-2,2-dimethylvinyl)-2-oxazolidinone
(2S,3R)-5-Benzyl-3-iodo-2-phenyl-1-(toluene-4-sulfonyl)-2,3-dihydro-1H-pyrrole
4-[(E)-1,2-dimethylenepent-3-enyl]-5-methyl-3-(p-tolylsulfonyl)oxazolidin-2-one
3-Methyl-6-(3,4-dimethyl-5-phenyl-1,3-oxazolidin-2-yl)-3,4,5,6-tetrahydro-1,2-oxazine
Trimethyl-[(E)-2-[(2S,3S)-1-(4-methylphenyl)sulfonyl-3-(1-naphthalenyl)-2-aziridinyl]ethenyl]silane
2-(3-Pyridyl)-7-(p-toluenesulfonyl)-7-azabicyclo[2.2.1]hept-2-ene
dl-(1.alpha.,2.alpha.,4.alpha.,5.beta.,6.alpha.,7.alpha.)-6-bromo-3-(4-methylphenylsulfonyl)-8-oxa-3-azatricyclo[5.1.0.0(2,4)]octan-5-ol
| Title | Journal or Book | Year |
|---|---|---|
| An efficient protocol for Sharpless-style racemic dihydroxylation | Journal of the Chemical Society, Perkin Transactions 1 | 1999 |